1. Home >
  2. Companies >
  3. Life Science >
  4. Switzerland >
  5. B. Braun Medical - Critical Cell Therapy Manufacturing Assets

B. Braun Medical - Critical Cell Therapy Manufacturing Assets - Ownership and Business Overview

Life ScienceCompany

B. Braun Medical - Critical Cell Therapy Manufacturing Assets Ownership

Who owns B. Braun Medical - Critical Cell Therapy Manufacturing Assets?

B. Braun Medical - Critical Cell Therapy Manufacturing Assets is owned by Healiva SA. It was acquired on November 21, 2022.

B. Braun Medical - Critical Cell Therapy Manufacturing Assets Business Overview

Where is B. Braun Medical - Critical Cell Therapy Manufacturing Assets headquartered?

B. Braun Medical - Critical Cell Therapy Manufacturing Assets is headquartered in Switzerland.

What sector is B. Braun Medical - Critical Cell Therapy Manufacturing Assets in?

B. Braun Medical - Critical Cell Therapy Manufacturing Assets is a life science company.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Subscribe to Mergr to view all 299 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 262 by strategics.

B. Braun Medical - Critical Cell Therapy Manufacturing Assets

B. Braun Medical - Critical Cell Therapy Manufacturing Assets


Switzerland,

B. Braun Medical's Critical Cell Therapy Manufacturing Assets provides cell therapy products.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for B. Braun Medical - Critical Cell Therapy Manufacturing Assets

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal